The diet drug rimonabant (Acomplia), which has been approved for use in Europe and a number of other countries but not the United States, proves to be useful in blocking the development of alcoholic fatty liver, according to …

The new and exciting about Acomplia is that it functions very differently to the other medication in the same field such as Phentermine, Reductil and Xenical.  Reductil and Phentermine  are also appetite suppressants …